05/16/2024
6:20 PM | BOHLIN GAREN G (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:21 PM | Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:22 PM | Balice-Gordon Rita J. (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:22 PM | Collegium Pharmaceutical (Issuer)
Fallon John A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:22 PM | Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:23 PM | Collegium Pharmaceutical (Issuer)
McFarlane Neil F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:23 PM | Collegium Pharmaceutical (Issuer)
Melincoff Gwen A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/16/2024
6:23 PM | Collegium Pharmaceutical (Issuer)
SANTINI GINO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
2:12 PM | BOHLIN GAREN G (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024
7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
7:02 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
7:03 AM | Collegium Pharmaceutical (Filer)
| Form DEFA14A | |
05/09/2024
3:07 PM | Collegium Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
7:00 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
3:26 PM | Collegium Pharmaceutical (Issuer)
Smith Thomas B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:24 PM | Collegium Pharmaceutical (Subject)
Smith Thomas B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
3:14 PM | Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
3:39 PM | Collegium Pharmaceutical (Subject)
Dreyer Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
11:04 AM | Collegium Pharmaceutical (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/12/2024
5:06 AM | Collegium Pharmaceutical (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
01/19/2024
1:40 PM | BlackRock Inc. (Filed by)
Collegium Pharmaceutical (Subject)
| Form SC 13G/A | |
01/18/2024
3:19 PM | Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
7:03 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
3:36 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
4:51 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:28 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023
3:32 PM | Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
4:00 PM | Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023
7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2023
6:40 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2023
9:19 AM | Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/02/2023
6:08 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
9:04 AM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023
3:10 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023
3:15 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
8:58 AM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2023
11:10 AM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/19/2023
3:37 PM | BOHLIN GAREN G (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
3:38 PM | Collegium Pharmaceutical (Issuer)
SANTINI GINO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad) Are you monitoring 13,217 cryptocurrencies everyday?
If not, you could miss the ONE that can make you wealthy beyond your wildest dreams.
You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. |
05/19/2023
3:38 PM | Collegium Pharmaceutical (Issuer)
Melincoff Gwen A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
3:39 PM | Collegium Pharmaceutical (Issuer)
Fallon John A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
3:39 PM | Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
3:40 PM | Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
3:40 PM | Collegium Pharmaceutical (Issuer)
McFarlane Neil F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
3:40 PM | Balice-Gordon Rita J. (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
